Memorable trades executed with commentaries for this week.
December 9, 2024 to December 13, 2024 4:00 PM
For this week a hypothetical investment of $10,000 yielded $18,564 (that's right … $18,564 in net gains from the companies of our memorable trades. Naturally, the fully documented results as stated may not represent future transactions, but if history is the judge, our G-101-SPM AI algorithm is the cat’s meow.
... And now for the score. **For seven week of memorable trade
10.28.24 - 11.01.24 $ 63,273 GAIN
11.04.24 - 11.08.24 $ 99,192 GAIN
11.11.24 - 11.15.24 $ 24,328 GAIN
11.25.24 - 11.29.24 $ 13,959 GAIN
12.02.24 -12.06.24 $100,959 GAIN
12.09.24 -12.13.24 $ 18,564 GAIN
That's right ... $320,275 TOTAL GAIN
** Each trade is time stamped and verified. Spend the time and check for yourself.
Every second, every minute, every hour and every action of the trading day has proved
chatbot is far superior than the other kinds.
PART ONE
12.13.24
$EBS $8.45 bid. *DAC (dollar average cost includes partial sale to reduce net cost to zero). EXIT $20.00.
UPDATE: Emergent BioSolutions awarded $50 mln BARDA contract for Anthrax Vaccine (approved 12/12/24).
* Click SEARCH (magnifying glass) icon on our landing page to review the postings.
12.13.24
$CADL $6.40 ask. BUY/ADD TO LONG POSITION.
** DAC (dollar average cost includes partial sales that reduced to cost to a credit of $4.54 p[er share. This trade has a net cost from surplus profit of $1.83 per share.)
EXIT $25.00 LH status.
** Click SEARCH (magnifying glass) icon on our landing page to review the postings.
12.13.24
$LAES $1.61 bid. DAC (dollar average cost) $1.175 (12.11.24). EXIT $5.00
UPDATE: Today announced purchase agreement with several institutional investors to purchase 7,692,308 ordinary shares at a public offering price of $1.30, for gross proceeds of $10.0 million; closing December 16, 2024.
note: Cash to fund its next-generation post-quantum semiconductor technology and ASIC capabilities in the United States.
12.13.24
$CADL $6.73 bid. DAC (dollar average cost includes partial sales to reduce cost to zero / last BUY at $1.04 (12.14.23). EXIT $25.00 - Legacy Holding status.
UPDATE/ May cause limited dilution. RETAIN POSITION.
Co announced the pricing of an underwritten public offering of 10,000,001 shares of its common stock at a price to the public of $6.00 per share and pre-funded warrants to purchase up to an aggregate of 3,333,333 shares of its common stock at a price to the public of $5.99 per pre-funded warrant to purchase one share of the common stock.
CALLED…
$CADL ($6.78 -$3.01) temporary sell off with this post on the 12.11.24 under OPTIONACTION
$CADL Dec 4 puts are seeing interest with the underlying stock up 59% (volume: 1.4K, open int: 790, implied vol: ~221%, prev day implied vol: 97%). Co announces results from a multicenter phase 3 clinical trial evaluating CAN-2409 viral immunotherapy in localized prostate cancer patients. Co is expected to report earnings mid-March.
note: BUY ON DIPS/
EXIT at $25.00 as Legacy Holding status is as good as a "guarantee," according to the SPM LH performance on the last 50 picks, which is 91.53%
12.12.24
$NNE $25.42 +1.34. DAC (dollar average cost) $20.64 (10.30.24). EXIT $45.00.
BRIEF:LIS Technologies and NANO Nuclear Energy are One of Six Awarded U.S. Department of Energy Contracts ($2 M each) as Part of Low-Enriched Uranium Acquisition Program with An Aggregate Appropriation of $3.4 Billion Over 10 years.
12.12.24
$QSI $2.13 bid. DAC (dollar average cost) $1.38. EXIT $4.00.
BRIEF: Announced that it has expanded its international distribution network to a total of 15 partners. The commercial distribution network includes further expansion across Western Europe, Eastern Europe and Asia, as well as new expansion into Middle East, Africa, South America and the South Pacific regions.
12.12.24
$DDD $3.43 bid. DAC (2) $2.905 / last $1.91 (9.4.24).
CHANGE EXIT TO $6.00 FROM $4.25.
BRIEF: Following a strategic review of the Company's software investment strategy, 3D Systems announced that it has signed a definitive agreement to sell its Geomagic software portfolio to the Manufacturing Intelligence Division of Hexagon, a global leader in digital reality solutions, combining sensor, software, and autonomous technologies, for $123 million. The transaction is expected to close in the first half of 2025, following the completion of customary regulatory reviews.
12.12.24
$ACAD $18.02 last bid. *DAC (dollar average cost including partial sale / reduced cost to $13.02). EXIT $23.00.
UPDATE: Today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $150 million before fees and expenses.
* Click SEARCH (magnifying glass) icon on our landing page to review the postings.
12.11.24
$U $27.08 bid. DAC (dollar average cost includes partial liquidation to reduce net cost to $18.09).
CHANGE EXIT TO $34.00 FROM $25.00.
OPTIONACTION
$U Weekly Dec13 32 calls (volume: 2.5K, open int: 570, implied vol: ~91%, prev day implied vol: 75%).
note: Co is expected to report earnings late January.
12.11.24
$VRAR $1.48 bid. DAC (dollar average cost) $1.00 (12.10.24. EXIT $2.50.
BRIEF:
SEC FORM 4
Lyron L. Bentovim 12/11/2024
Reflects common stock acquired by the Reporting person on December 11, 2024
^ Represents the average purchase price for the Company's shares.
^ The indirect beneficial ownership set forth above includes 1,001,945 shares indirectly held by Mr. Bentovim (through Darklight Partners LLC - an entity owned and managed by Mr. Bentovim), which indirect beneficial ownership was unaffected by the transaction reported above.
12.11.14
$PLAB $29.65 bid. SELL/TAKE PROFIT.
DAC (dollar average cost) $25.25. (12.10.24)
12.11.24
$RGTI $7.15 bid. DAC (4) $1.093. EXIT $10.00.
BRIEF: Rigetti, Quantum Machines Automate Quantum Computer Calibration; Shares Rise Premarket
Rigetti Computing (RGTI) and Quantum Machines said Tuesday they successfully automated the calibration of a quantum computer using artificial intelligence.
note: Shares of Rigetti were almost 11% higher in premarket activity on Wednesday after closing up more than 45% on Tuesday.
12.11.24
$PLAB $26.00 bid/$27.65 ask. DAC (dollar average cost) $25.25 (earnings play EB12.11). EXIT $28.00.
UPDATE: Reports Q4 (Oct) earnings of $0.59 per share, $0.07 better than the single analyst estimate of $0.52; revenues fell 2.2% year/year to $222.6 mln vs the $218 mln single analyst estimate.
Co issues in-line guidance for Q1, sees EPS of $0.43-0.49 vs. $0.46 single analyst estimate; sees Q1 revs of $208-216 mln vs. $210.00 mln single analyst estimate.
12.10.24
FLASHTRADE
$ALK $61.37 +7.21 bid. SELL/TAKE PROFIT.
DAC (dollar average cost) $55.01 (12.10.24.)
PLAN TO REVISIT
12.10.24
$GSAT $2.39 bid. DAC (dollar average cost) $1.514 (11.4.24).
CHANGE EXIT TO $4.50 FROM $3.00.
BRIEF:
^ Globalstar shares spiking higher in recent trade following report that Apple (AAPL) is preparing a blood pressure tool for Apple Watch
^Globalstar (GSAT) announced that the United States Federal Communications Commission has issued a radio station authorization to GUSA Licensee LLC granting it a 15-year renewal of its authority to operate numerous categories of mobile earth terminals with its U.S. and French-licensed NGSO satellites throughout the United States and its territories.
^PSN and GSAT exclusive partnership.
12.10.24
$NRDY $1.73 bid. DAC (dollar average cost) (11) $1.11 / last $0.942 (8.9.24). EXIT $2.50.
BRIEF: NRDY Chief Executive Officer and one (1) Director bought 459,813 shares worth approximately $706K.
12.10.24
OPTIONACTION
$RGTI $5.72 +1.26. DAC (dollar average cost) (4) $1.093 / last $0.7912 (10.7.24). EXIT $6.00.
UPDATE: Bullish option flow detected in Rigetti Computing(RGTI) with 18,691 calls trading, 4x expected, and implied vol increasing almost 8 points to 184.93%. Dec-24 5 calls and Dec-24 6 calls are the most active options, with total volume in those strikes near 5,300 contracts. The Put/Call Ratio is 0.12. Earnings are expected on March 13th.
12.10.24
$ALK $58.75 +4.59. DAC (dollar average cost) $55.01 (12.10.24). EXIT $68.00.
OVERRVIEW: Alaska Air Group Issues Earnings Outlooks, Expanded Route Network, New Asia Flights
Alaska Air Group(ALK) said Tuesday it expects 2025 earnings of at least $5.75 per share and increased capacity of 2% to 3%. Analysts polled by SPM tag expects EPS of $5.55.
^^ It also said it was setting a 2027 financial earnings target of at least $10 per share. A single analyst polled by FactSet expects EPS of $7.95.
^^ The airline said it intends to double cargo revenue over the next few years and will open a new global hub in Seattle to combine Alaska Air(ALK) and Hawaiian Airlines route networks "to optimize connections and deepen relevance" for passengers.
note: The company said it will also offer new nonstop connections from Seattle to Tokyo and Seoul on Airbus A330 aircraft beginning next year.
12.10.24
$QURE $14.88 +$7.50. SELL/ TAKE PROFIT ON 50% OF LONG POSITION.
DAC (dollar average cost without reduction on 50% sale of open position) (3) $8.63 / last $6.75 (2.28.24).
CHANGE LONG TERM EXIT TO $28.00 FROM $15.00 (maintain LH status).
BRIEF: uniQure Reaches Agreement With FDA On Key Elements Of An Accelerated Approval Pathway For AMT-130
As part of uniQure's Regenerative Medicine Advanced Therapy (RMAT) Type B meeting held in late November, the FDA agreed that data from the ongoing Phase I/II studies, compared to a natural history external control, may serve as the primary basis for a BLA submission under the Accelerated Approval pathway, avoiding the need for an additional pre-submission study.
The FDA also agreed that cUHDRS may be used as an intermediate clinical endpoint and that reductions in neurofilament light chain (NfL) measured in cerebrospinal fluid (CSF) may serve as supportive evidence of therapeutic benefit in the application for accelerated approval.
12.9.24
$YEXT $7.66 bid. DAC (dollar average cost) (3) $5.64 / last $4.24 (6.10.24. EXIT $12.00.
RETAIN POSITION.
BRIEF: Reports Q3 (Oct) earnings of $0.12 per share in-line with consensus; revenues rose 12.6% year/year to $114 mln vs the $113.21 mln.
Total ARR increased to $441.8 million.
Co issues in-line guidance for FY25, sees FY25 revs of $420.3-$420.8 mln vs. $420.53 mln consensus.
12.9.24
$ASAN $24.98 bid. SELL 50% of long position/TAKE PROFIT.
DAC (dollar average cost without the profit on 50% liquidations of position is $15.635 last / trade at $12.44 (8.12.24).
EXIT $32.00 (maintain Legacy Holding (LH) status.
12.9.24
$GH $36.48 bid. * DAC (dollar average cost) (6) $26.46 last $23.00 (9.16.24). EXIT $50.00.
NEWS: Today announced the company and its research collaborators will present data demonstrating the benefits of its precision oncology tests, real-world clinical-genomic database and AI analytics in optimizing therapy selection, identifying resistance mutations, and predicting long-term outcomes at the San Antonio Breast Cancer Symposium (SABCS) 2024 in San Antonio, Texas, Dec. 10-13, 2024.
note: The investigators conclude that ctDNA could be a valuable tool in predicting long-term outcomes and in tailoring treatment approaches.
Craig Eagle, M.D., chief medical officer at Guardant Health, said, "We look forward to sharing new studies at SABCS that show how Guardant is working with researchers and cancer care teams to improve outcomes for people living with breast cancer."
* Click SEARCH (magnifying glass) icon on our landing page to review the postings.
12.9.24
$TSAT $17.19 bid. SELL/TAKE PROFIT.
DAC (dollar average cost) (2) $12.97 last $10.65 (11.29.23).
Plan to REVISIT.
12.9.24
$PATH $15.00 bid. SELL/TAKE PROFIT on neutral SPM tag.
DAC (dollar average cost) (7) $12.71 last $11.33 (6.17.24).
12.9.24
$AAP $45.00 bid. DAC $39.835 (11.12.24).
CHANGE EXIT $52.00 FROM $45.00 on improved SPM tag.
12.9.24
$SMCI $46.31 bid. DAC (dollar average cost) (2) $38.475 (12.2.24). EXIT $50.00.
CHANGE EXIT TO $65.00 FROM $50.00 on improved SPM tag.
BRIEF: Today announced that on December 6, 2024, it received a letter from the Nasdaq Stock Market informing the Company that Nasdaq has granted the Company's request for an exception to Nasdaq's Listing Rule 5250(c)(1) through February 25, 2025. The exception gives the Company until February 25, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024, its Quarterly Report on Form 10-Q for the period ended September 30, 2024 and any other required filings.
note: The Company's common stock will remain listed on the Nasdaq Global Select Market during the exception period. If the Company files all the required reports by February 25, 2025, the common stock will remain listed, so long as the Company remains in compliance with Nasdaq's listing rules.
12.9.24
UPDATE AS TO LAST BUY
$RGTI $5.07 bid. DAC (dollar average cost) (4) $1.093 last $0.79 (10.7.27).
CHANGE EXIT TO $10.00 FROM $6.00 on improved SPM tag.
12.9.24
$RGTI $5.07 bid. DAC (dollar average cost) (4) $1.093 last (10.7.27).
CHANGE EXIT TO $10.00 FROM $6.00 on improved SPM tag.
OVERVIEW: Rigetti Computing's model similar to Nvidia's; serves the infrastructure side of this opportunity, building quantum computers and their key hardware components like processors. The company has also developed its Quantum Cloud Services platform designed to give clients access to its quantum processors remotely through the cloud.
Rigetti has designed QCS to integrate with traditional computer hardware, making it easier for customers to access the technology; represent huge cost savings for a client compared to building its own quantum computing capabilities in-house.
note: Quantum computers are computers that use quantum mechanics to solve problems much faster than their traditional alternatives.
PART TWO
Our AI algorithm is an investment predictor that gathers data from 129 preset sources and presents the values as a SPM matrix number. The database tracks over 5215 individual stocks with each one carrying a "floating" SPM tag. The higher the value the greater the subjective probability of the collective data being accurate, and culminating with the issuance of an auxiliary SPM tag.
^Follow the daily abstracts: SPMNOTES, FIRSTLOOK, OPTIONACTION, INSIDERS, DILUTION, SHOWTIME, NOISE, FLASHTRADE, QUESTIONBOX and SURVEY.
^DAC means “dollar average cost” and determines the true cost of the investment position during the cycle of the trade.
IDEA: Devote quality time to understand how to apply the data as a "positional investor."
* Click https://stocktwits.com/G101SPM SEARCH on (magnifying glass) icon on our landing page to review the postings.
MISSION STATEMENT: To prove that non-human intervention by an analytical chatbot is far superior than the other kinds. The rise of generative AI (GenAI) models, like OpenAI’s GPT, has accelerated our transformation. In the process we have become Number One in non-human investment/enterprise analytics.
Our tools do more than process data, G-101 SPM AI generates world-class content, fully automates workflows, and unlocks insights in ways traditional AI can never achieve.
WE'LL MATCH OUR TRACK RECORD TO ANYONE OR ANY THING.
To date not one firm or individual has challenged us or even matched or questioned our transparence.
ARE YOU READY TO MAKE BIG MONEY IN THE STOCK MARKET?
Comments